Sangamo Therapeutics
SGMO
#10511
Rank
A$30.01 M
Marketcap
A$0.07245
Share price
-28.57%
Change (1 day)
-90.73%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of September 2025 : A$42.91 Million

According to Sangamo Therapeutics 's latest financial reports the company has A$42.91 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$67.39 M-43.32%
2023-12-31A$0.11 B-70.86%
2022-12-31A$0.40 B-21.45%
2021-12-31A$0.51 B-37.74%
2020-12-31A$0.83 B61.13%
2019-12-31A$0.51 B-8.85%
2018-12-31A$0.56 B82.25%
2017-12-31A$0.31 B57.61%
2016-12-31A$0.19 B-31.08%
2015-12-31A$0.28 B31.2%
2014-12-31A$0.21 B110.16%
2013-12-31A$0.10 B70.16%
2012-12-31A$61.15 M-25.47%
2011-12-31A$82.05 M38.25%
2010-12-31A$59.34 M-37.23%
2009-12-31A$94.55 M2.9%
2008-12-31A$91.89 M-0.92%
2007-12-31A$92.74 M35.6%
2006-12-31A$68.4 M6.59%
2005-12-31A$64.17 M49.31%
2004-12-31A$42.97 M-27.15%
2003-12-31A$59 M-36.25%
2002-12-31A$92.55 M-23.32%
2001-12-31A$0.12 B6.25%
2000-12-31A$0.11 B882.14%
1999-12-31A$11.56 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$31.95 B 74,356.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$17.44 B 40,546.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$6.20 B 14,360.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$5.58 B 12,903.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$11.07 B 25,707.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$8.26 B 19,153.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$4.36 B 10,060.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$3.22 B 7,404.19%๐Ÿ‡บ๐Ÿ‡ธ USA